← Leaderboards
Eleonore Beurel
University Of Alabama At Birmingham
$7,525,473
Attributed
$8,346,770
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,346,770 · 7
By mechanism
R01$7,484,757 · 5
R00$682,671 · 1
K99$179,342 · 1
Top collaborators
- Michal J. Toborek3 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- James M Shikany$12,027,044
- Selwyn M Vickers$28,481,364
- Upender Manne$11,389,346
- Raegan Winston Durant$3,368,553
- Isabel C Scarinci$19,061,797
Others in their field
Top investigators on “Mental Depression”
- Sharon A Nachman · Johns Hopkins University$74,725,055
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$51,306,513
- Joseph J Mann · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc$39,648,249
- Boris Birmaher · University Of Pittsburgh At Pittsburgh$32,263,758
- Carol D. Ryff · University Of Wisconsin Madison$30,932,130
- Ned H Kalin · University Of Wisconsin-Madison$28,068,100
Research focus
Mental DepressionPredispositionBrainMajor Depressive DisorderDepressive SymptomsBehaviorStressProductionLinkCytokineInflammatoryCellsInflammationChronicSignal TransductionInflammatory ResponseMediatingBacteriaImmune SystemLearned HelplessnessAffectImmuneMultiple SclerosisResistance
Grant awards (24)
Inflammasome Activation and Gut-Brain Axis Dysregulation in HIV and Methamphetamine-Associated Depression$575,379
R01 · FY2025 · DA
Autoinducer-2 and depression$549,140
R01 · FY2025 · MH · contact PI
Adolescent exposure to PCBs as a risk factor for the development of depression$495,980
R01 · FY2025 · ES
Inflammasome Activation and Gut-Brain Axis Dysregulation in HIV and Methamphetamine-Associated Depression$571,235
R01 · FY2024 · DA
Th17 cells as a new therapeutic target for depression$383,750
R01 · FY2024 · MH · contact PI
Th17 cells as a new therapeutic target for depression$383,750
R01 · FY2023 · MH · contact PI
Th17 cells as a new therapeutic target for depression$383,750
R01 · FY2022 · MH · contact PI
Th17 cells as a new therapeutic target for depression$345,885
R01 · FY2021 · MH · contact PI
The microbiota, a possible link between Th17 cells and depression$307,000
R01 · FY2021 · MH · contact PI
Th17 cells as a new therapeutic target for depression$383,750
R01 · FY2020 · MH · contact PI
The microbiota, a possible link between Th17 cells and depression$307,000
R01 · FY2020 · MH · contact PI
Th17 cells as a new therapeutic target for depression$383,750
R01 · FY2019 · MH · contact PI
The microbiota, a possible link between Th17 cells and depression$307,000
R01 · FY2019 · MH · contact PI
Th17 cells as a new therapeutic target for depression$383,750
R01 · FY2018 · MH · contact PI
The microbiota, a possible link between Th17 cells and depression$303,323
R01 · FY2018 · MH · contact PI
Th17 cells as a new therapeutic target for depression$383,750
R01 · FY2017 · MH · contact PI
The microbiota, a possible link between Th17 cells and depression$301,165
R01 · FY2017 · MH · contact PI
Th17 cells as a new therapeutic target for depression$383,750
R01 · FY2016 · MH · contact PI
Th17 cells as a new therapeutic target for depression$351,650
R01 · FY2015 · MH · contact PI
Interactions Between Depression, Neuroinflammation and Glycogen Synthase Kinase-3$242,692
R00 · FY2014 · MH · contact PI
Interactions Between Depression, Neuroinflammation and Glycogen Synthase Kinase-3$190,978
R00 · FY2013 · MH · contact PI
Interactions Between Depression, Neuroinflammation and Glycogen Synthase Kinase-3$249,001
R00 · FY2012 · MH · contact PI
Interactions Between Depression, Neuroinflammation and Glycogen Synthase Kinase-3$89,342
K99 · FY2011 · MH · contact PI
Interactions Between Depression, Neuroinflammation and Glycogen Synthase Kinase-3$90,000
K99 · FY2010 · MH · contact PI